Florexia

is a medical device, a symbiotic solution designed to help restore vaginal microbiota balance. It is available in the form of vaginal suppositories containing the L. ARC probiotic complex, which includes the most common Lactobacillus strains: Lactobacillus acidophilus, Lactobacillus rhamnosus, and Lactobacillus crispatus, as well as lactic acid. All three bacterial strains colonize the vaginal epithelium, helping to establish colonization resistance.

Composition:

1 suppository contains: Lactobacillus crispatus 1 × 10⁸ CFU, Lactobacillus rhamnosus 1 × 10⁸ CFU, Lactobacillus acidophilus 1 × 10⁸ CFU, lactic acid; excipients: semi-synthetic glycerides.

Directions for use:

Administer vaginally, 1 suppository once or twice daily (in the morning and/or at bedtime) for 7–14 days. If necessary, the course may be repeated.

Contraindications:

Hypersensitivity to any of the product components.

Warnings:

Consultation with a healthcare professional is recommended before use. The product is generally well tolerated; however, allergic reactions may occur in isolated cases.

Medical device Florexia

Not a medicinal product.

Storage conditions:

Store in the original packaging at a temperature not exceeding 25°C. Keep out of the reach of children.

Manufacturer:

LLC “OLIVIN PHARM”
16-G Voskresenska St., Office 37, Kyiv 02125, Ukraine
E-mail: olivinpharm@olivinpharm.com.ua
Tel.: +38 068 508 23 62

Manufacturing site address:

PJSC “Monpharm”
8 Zavodska St., Avramivka Village, Uman District, Cherkasy Region 19161, Ukraine

Official distributor:

LLC “SYSTEM PHARM”
100/5 Shevchenka St., Boryspil, Kyiv Region 08300, Ukraine
Tel.: +38 097 073 00 48

Advertising of a medical device. Not a medicinal product. Consult your healthcare professional before using this medical device.